Relation between antitumor efficacy of cyclin-dependent cyclin kinase inhibitor seliciclib and drug effects on clock and cell cycle genes

被引：0
|
作者：
不详
机构：
来源：
CHRONOBIOLOGY INTERNATIONAL | 2005年 / 22卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：1178 / 1179
页数：2
相关论文
共 50 条
  • [1] Liver Circadian Clock, a Pharmacologic Target of Cyclin-Dependent Kinase Inhibitor Seliciclib
    Iurisci, Ida
    Filipski, Elisabeth
    Sallam, Hatem
    Harper, Francis
    Guettier, Catherine
    Maire, Irene
    Hassan, Moustapha
    Iacobelli, Stefano
    Levi, Francis
    CHRONOBIOLOGY INTERNATIONAL, 2009, 26 (06) : 1169 - 1188
  • [2] Improved tumor control through circadian clock induction by seliciclib, a cyclin-dependent kinase inhibitor
    Iurisci, Ida
    Filipski, Elisabeth
    Reinhardt, Jens
    Bach, Stephane
    Gianella-Borradori, Athos
    Iacobelli, Stefano
    Meijer, Laurent
    Levi, Francis
    CANCER RESEARCH, 2006, 66 (22) : 10720 - 10728
  • [3] Liver effects of cyclin-dependent kinase inhibitor seliciclib. Relations with circadian pharmacokinetics and liver clock disruption
    Ida, Lurisci
    Filipsi, Elizabeth
    Hassan, Moustapha
    Sallam, Hatern
    Pham, Patrick
    Hossard, Virginie
    Iacobelli, Stefano
    Levi, Francis A.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3369S - 3369S
  • [4] The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kinetics
    Schutte, B
    Nieland, L
    vanEngeland, M
    Henfling, MER
    Meijer, L
    Ramaekers, FCS
    EXPERIMENTAL CELL RESEARCH, 1997, 236 (01) : 4 - 15
  • [5] Antitumor effects of a covalent cyclin-dependent kinase 7 inhibitor in colorectal cancer
    Wang, Jian
    Li, Zhenyu
    Mei, Hong
    Zhang, Dejun
    Wu, Gang
    Zhang, Tao
    Lin, Zhenyu
    ANTI-CANCER DRUGS, 2019, 30 (05) : 466 - 474
  • [6] Flavopiridol, a cyclin-dependent kinase inhibitor
    Lansiaux, A
    Bailly, C
    BULLETIN DU CANCER, 2000, 87 (10) : 697 - 701
  • [7] Cyclin-dependent kinase inhibitor seliciclib shows in vitro activity in diffuse large B cell lymphomas.
    Bertoni, Francesco
    Lacrima, Katia
    Rinaldi, Andrea
    Vignati, Sara
    Martin, Vittoria
    Tibiletti, Maria Grazia
    Gaidano, Gianluca
    Catapano, Carlo C.
    MacCallum, David E.
    BLOOD, 2006, 108 (11) : 267B - 268B
  • [8] Cyclin-dependent kinase inhibitor seliciclib shows in vitro activity in diffuse large B-cell lymphomas
    Lacrima, Katia
    Rinaldi, Andrea
    Vignati, Sara
    Martin, Vittoria
    Tibiletti, Maria Grazia
    Gaidano, Gianluca
    Catapano, Carlo V.
    Bertoni, Francesco
    LEUKEMIA & LYMPHOMA, 2007, 48 (01) : 158 - 167
  • [9] The Development of a Selective Cyclin-Dependent Kinase Inhibitor That Shows Antitumor Activity
    Ali, Simak
    Heathcote, Dean A.
    Kroll, Sebastian H. B.
    Jogalekar, Ashutosh S.
    Scheiper, Bodo
    Patel, Hetal
    Brackow, Jan
    Siwicka, Alekasandra
    Fuchter, Matthew J.
    Periyasamy, Manikandan
    Tolhurst, Robert S.
    Kanneganti, Seshu K.
    Snyder, James P.
    Liotta, Dennis C.
    Aboagye, Eric O.
    Barrett, Anthony G. M.
    Coombes, R. Charles
    CANCER RESEARCH, 2009, 69 (15) : 6208 - 6215
  • [10] Seliciclib, a cell-cycle modulator that acts through the inhibition of cyclin-dependent kinases
    Jackson, Robert C.
    Barnett, Anna L.
    McClue, Steven J.
    Green, Simon R.
    EXPERT OPINION ON DRUG DISCOVERY, 2008, 3 (01) : 131 - 143
12345